Anti-tumour Effects of 5-hydroxytryptamine (5-HT) are Not Entirely Attributable to Its Effects on Tumour Vasculature

D.C. Jenkins Department of Molecular Sciences, Wellcome Research Laboratories, Langley Court, Beckenham, Kent, BR3 3BS, UK

J. Wilkinson Department of Physical Sciences, Wellcome Research Laboratories, Langley Court, Beckenham, Kent, BR3 3BS, UK

J.C. Lindon Herchel Smith Laboratory for Medicinal Chemistry, University of Cambridge, Cambridge, UK

R.D. Farrant Department of Molecular Sciences, Wellcome Research Laboratories, Langley Court, Beckenham, Kent, BR3 3BS, UK

T.A. Carpenter Department of Physical Sciences, Wellcome Research Laboratories, Langley Court, Beckenham, Kent, BR3 3BS, UK

J.N. Stables Herchel Smith Laboratory for Medicinal Chemistry, University of Cambridge, Cambridge, UK

P. Topley Department of Molecular Sciences, Wellcome Research Laboratories, Langley Court, Beckenham, Kent, BR3 3BS, UK

D.J. Lindstead Department of Physical Sciences, Wellcome Research Laboratories, Langley Court, Beckenham, Kent, BR3 3BS, UK

L.S. Holmes Herchel Smith Laboratory for Medicinal Chemistry, University of Cambridge, Cambridge, UK

show all

References

Cater D.B., Grigson C.M.B., Watkinson D.A. Changes of oxygen tension in tumours induced by vasoconstrictor and vasodilator drugs. Acta Radiologica 1962; 58: 401–434
PubMed Web of Science ®Google Scholar
Cater D.B., Petrie A., Watkinson D.A. Effect of 5-hydroxytryptamine and cyproheptadine on tumour blood flow. Acta Radiologica, Therapy, Physics, Biology 1965; 3: 109–128
PubMed Web of Science ®Google Scholar
Corbett T.H., Griswold D.P., Roberts B.J., Peckham J.C., Schabel F.M. Tumour induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Research 1975; 35: 2434–2439
PubMed Web of Science ®Google Scholar
Knapp W.H., Debatin J., Layer K., Kelus F., Altmann A., Sinn H.-J., Ostertag H. Selective drug-induced reduction of blood flow in tumour transplants. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 1357–1365
PubMed Web of Science ®Google Scholar
Manda T., Nishigaki F., Mori J., Shimomura K. Important role of serotonin in the antitumour effects of recombinant human tumour necrosis factor-α in mice. Cancer Research 1988; 48: 4250–4255
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Anti-tumour Effects of 5-hydroxytryptamine (5-HT) are Not Entirely Attributable to Its Effects on Tumour Vasculature

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Anti-tumour Effects of 5-hydroxytryptamine (5-HT) are Not Entirely Attributable to Its Effects on Tumour Vasculature

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date